<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39403385</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study.</ArticleTitle><Pagination><StartPage>1430899</StartPage><MedlinePgn>1430899</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1430899</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1430899</ELocationID><Abstract><AbstractText Label="BACKGROUNDS" NlmCategory="UNASSIGNED">During the Coronavirus Disease 2019 (COVID-19) epidemic, the massive spread of the disease has placed an enormous burden on the world's healthcare and economy. The early risk assessment system based on a variety of machine learning (ML) algorithms may be able to provide more accurate advice on the classification of COVID-19 patients, offering predictive, preventive, and personalized medicine (PPPM) solutions in the future.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective study, we divided a portion of the data into training and validation cohorts in a 7:3 ratio and established a model based on a combination of two ML algorithms first. Then, we used another portion of the data as an independent testing cohort to determine the most accurate and stable model and compared it with other scoring systems. Finally, patients were categorized according to risk scores and then the correlation between their clinical data and risk scores was studied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The elderly accounted for the majority of hospitalized patients with COVID-19. The C-index of the model constructed by combining the stepcox[both] and survivalSVM algorithms was 0.840 in the training cohort and 0.815 in the validation cohort, which was calculated to have the highest C-index in the testing cohort compared to the other 119 ML model combinations. Compared with current scoring systems, including the CURB-65 and several reported prognosis models previously, our model had the highest AUC value of 0.778, representing an even higher predictive performance. In addition, the model's AUC values for specific time intervals, including days 7,14 and 28, demonstrate excellent predictive performance. Most importantly, we stratified patients according to the model's risk score and demonstrated a difference in survival status between the high-risk, median-risk, and low-risk groups, which means a new and stable risk assessment system was built. Finally, we found that COVID-19 patients with a history of cerebral infarction had a significantly higher risk of death.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This novel risk assessment system is highly accurate in predicting the prognosis of patients with COVID-19, especially elderly patients with COVID-19, and can be well applied within the PPPM framework. Our ML model facilitates stratified patient management, meanwhile promoting the optimal use of healthcare resources.</AbstractText><CopyrightInformation>Copyright © 2024 Qin, Li, Zhu, Yu, Peng, Wu, Xu, Gu and Guo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Qin</LastName><ForeName>Qiangqiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Qingxuan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Guiyin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Mingyan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Stomatologic Hospital and College, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006403" MajorTopicYN="N">Hematologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">categorized treatment</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">predictive model</Keyword><Keyword MajorTopicYN="N">predictive preventive personalized medicine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39403385</ArticleId><ArticleId IdType="pmc">PMC11471604</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1430899</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Che Y, Jiang D, Zhang Y, Zhang J, Xu T, Sun Y, et al. . Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection. Clin Transl Med. (2022) 12:e1103. doi: 10.1002/ctm2.1103</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.1103</ArticleId><ArticleId IdType="pmc">PMC9708907</ArticleId><ArticleId IdType="pubmed">36447039</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong YJ, Wi YM, Park H, Lee JE, Kim SH, Lee KS. Current and emerging knowledge in COVID-19. Radiology. (2023) 306:e222462. doi: 10.1148/radiol.222462</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.222462</ArticleId><ArticleId IdType="pmc">PMC9846833</ArticleId><ArticleId IdType="pubmed">36625747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartsch SM, Ferguson MC, McKinnell JA, O'Shea KJ, Wedlock PT, Siegmund SS, et al. . The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff (Millwood). (2020) 39:927–35. doi: 10.1377/hlthaff.2020.00426</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2020.00426</ArticleId><ArticleId IdType="pmc">PMC11027994</ArticleId><ArticleId IdType="pubmed">32324428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjodin H, Johansson AF, Brannstrom A, Farooq Z, Kriit HK, Wilder-Smith A, et al. . COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios. Int J Epidemiol. (2020) 49:1443–53. doi: 10.1093/ije/dyaa121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa121</ArticleId><ArticleId IdType="pmc">PMC7543571</ArticleId><ArticleId IdType="pubmed">32954400</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenzi KA, Al-Malky HS, Altebainawi AF, Abushomi HQ, Alatawi FO, Atwadi MH, et al. . Health economic burden of COVID-19 in Saudi Arabia. Front Public Health. (2022) 10:927494. doi: 10.3389/fpubh.2022.927494</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.927494</ArticleId><ArticleId IdType="pmc">PMC9642043</ArticleId><ArticleId IdType="pubmed">36388318</ArticleId></ArticleIdList></Reference><Reference><Citation>Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. (2022) 23:40–55. doi: 10.1038/s41580-021-00407-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00407-0</ArticleId><ArticleId IdType="pubmed">34518686</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. (2021) 13:152. doi: 10.1186/s13073-021-00968-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00968-x</ArticleId><ArticleId IdType="pmc">PMC8477474</ArticleId><ArticleId IdType="pubmed">34579788</ArticleId></ArticleIdList></Reference><Reference><Citation>Deo RC. Machine learning in medicine. Circulation. (2015) 132:1920–30. doi: 10.1161/CIRCULATIONAHA.115.001593</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.001593</ArticleId><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. . Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. (2020) 369:m1328. doi: 10.1136/bmj.m1328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, et al. . Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. (2022) 13:816. doi: 10.1038/s41467-022-28421-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28421-6</ArticleId><ArticleId IdType="pmc">PMC8831564</ArticleId><ArticleId IdType="pubmed">35145098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, Yan HJ, Huang H, Zuo YJ, Liu MZ, Zhao J, et al. . Machine learning-Based prognostic model for patients after lung transplantation. JAMA Netw Open. (2023) 6:e2312022. doi: 10.1001/jamanetworkopen.2023.12022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.12022</ArticleId><ArticleId IdType="pmc">PMC10163387</ArticleId><ArticleId IdType="pubmed">37145595</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al. . Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. (2020) 180:1081–9. doi: 10.1001/jamainternmed.2020.2033</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.2033</ArticleId><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning J, Sun K, Wang X, Fan X, Jia K, Cui J, et al. . Use of machine learning-based integration to develop a monocyte differentiation-related signature for improving prognosis in patients with sepsis. Mol Med. (2023) 29:37. doi: 10.1186/s10020-023-00634-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-023-00634-5</ArticleId><ArticleId IdType="pmc">PMC10029317</ArticleId><ArticleId IdType="pubmed">36941583</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, et al. . Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect. (2020) 81:e96–8. doi: 10.1016/j.jinf.2020.05.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.049</ArticleId><ArticleId IdType="pmc">PMC7255987</ArticleId><ArticleId IdType="pubmed">32474039</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM, Hong C, Xia Z, Palmer NP, Avillach P, L'Yi S, et al. . International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality. NPJ Digit Med. (2022) 5:74. doi: 10.1038/s41746-022-00601-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00601-0</ArticleId><ArticleId IdType="pmc">PMC9192605</ArticleId><ArticleId IdType="pubmed">35697747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. (2021) 93:786–93. doi: 10.1002/jmv.26300</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26300</ArticleId><ArticleId IdType="pmc">PMC7405288</ArticleId><ArticleId IdType="pubmed">32662893</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Chen S, Wang S, Yang S, Cao W, Liu S, et al. . Elevated D-dimer and adverse in-hospital outcomes in COVID-19 patients and synergism with hyperglycemia. Infect Drug Resist. (2022) 15:3683–91. doi: 10.2147/IDR.S367012</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S367012</ArticleId><ArticleId IdType="pmc">PMC9288185</ArticleId><ArticleId IdType="pubmed">35855759</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RS, Loscalzo J. Repurposing drugs for the treatment of COVID-19 and its cardiovascular manifestations. Circ Res. (2023) 132:1374–86. doi: 10.1161/CIRCRESAHA.122.321879</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321879</ArticleId><ArticleId IdType="pmc">PMC10171294</ArticleId><ArticleId IdType="pubmed">37167362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi H, Issac R, Sharma SK, Gupta R. Progressive left and right heart dysfunction in coronavirus disease-19: Prospective echocardiographic evaluation. Eur Heart J Cardiovasc Imaging. (2022) 23:319–25. doi: 10.1093/ehjci/jeab268</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab268</ArticleId><ArticleId IdType="pmc">PMC8754756</ArticleId><ArticleId IdType="pubmed">34904153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattey-Mora PP, Begle CA, Owusu CK, Chen C, Parker MA. Hospitalised versus outpatient COVID-19 patients’ background characteristics and comorbidities: A systematic review and meta-analysis. Rev Med Virol. (2022) 32:e2306. doi: 10.1002/rmv.2306</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2306</ArticleId><ArticleId IdType="pmc">PMC8646852</ArticleId><ArticleId IdType="pubmed">34674338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, et al. . Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. (2020) 12:165–74. doi: 10.21037/jtd</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd</ArticleId><ArticleId IdType="pmc">PMC7139011</ArticleId><ArticleId IdType="pubmed">32274081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenar SS, Deng Z. Development of artificial intelligence approach to forecasting oyster norovirus outbreaks along Gulf of Mexico coast. Environ Int. (2018) 111:212–23. doi: 10.1016/j.envint.2017.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2017.11.032</ArticleId><ArticleId IdType="pubmed">29232561</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Liu X, Kok SY, Rajarethinam J, Liang S, Yap G, et al. . Three-Month real-Time dengue forecast models: an early warning system for outbreak alerts and policy decision support in Singapore. Environ Health Perspect. (2016) 124:1369–75. doi: 10.1289/ehp.1509981</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1509981</ArticleId><ArticleId IdType="pmc">PMC5010413</ArticleId><ArticleId IdType="pubmed">26662617</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath S, Barnaby DP, Coppa K, Makhnevich A, Kim EJ, Chatterjee S, et al. . Machine learning to assist clinical decision-making during the COVID-19 pandemic. Bioelectron Med. (2020) 6:14. doi: 10.1186/s42234-020-00050-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42234-020-00050-8</ArticleId><ArticleId IdType="pmc">PMC7347420</ArticleId><ArticleId IdType="pubmed">32665967</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarkar G, Osmani F. Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study. Eur J Med Res. (2021) 26:79. doi: 10.1186/s40001-021-00553-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00553-3</ArticleId><ArticleId IdType="pmc">PMC8294317</ArticleId><ArticleId IdType="pubmed">34289910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, et al. . The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan. PloS One. (2020) 15:e0243602. doi: 10.1371/journal.pone.0243602</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243602</ArticleId><ArticleId IdType="pmc">PMC7774835</ArticleId><ArticleId IdType="pubmed">33382747</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. (2022) 269:1731–40. doi: 10.1007/s00415-021-10837-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10837-7</ArticleId><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>